Activity based costing of probation with and without substance abuse treatment: A case study

Journal of Mental Health Policy and Economics

Volumn 7, Issue 2, 2004, Pages 51-57

  Alemi, Farrokh ^a   Taxman, Faye ^b   Doyon, Victoria ^a   Thanner, Meridith ^b   Baghi, Heibatollah ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; BUDGET; CASE STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG DEPENDENCE TREATMENT; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HUMAN; PROBATION; QUESTIONNAIRE; RELIABILITY;

BUDGETS; COSTS AND COST ANALYSIS; CRIME; FEMALE; HUMANS; MALE; MENTAL HEALTH SERVICES; ORGANIZATIONAL CASE STUDIES; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS;

EID: 2942731609     PISSN: 10914358     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Visher CA. Incorporating drug treatment in criminal sanctions. National Institute of Justice Reports 1990; 221: 2-7.
2. Tolley G, Kenkel D, Fabian R. Valuing health for policy: An economic approach. Chicago: The University of Chicago Press, 1994.
3. Sloan FA. Valuing health care. New York: Cambridge University Press, 1996.
4. Kenkel D. On valuing morbidity, cost effectiveness analysis and being rude. J Health Econ 1997; 16: 749-757.
5. Johannesson M. Theory and methods of economic evaluation of health care. Dordrecht: Kluwer Academic Publishers, 1996.
6. Hargreaves WA, Shumnway M, Hu TW, Cuffel B. Cost-outcome methods for mental health. San Diego: Academic Press, 1998.
7. Drummond MF, O'Brian JO, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programs. Second edition. Oxford: Oxford University Press, 1997.
8. French MT, Salome HJ, Sindelar JL, McLellan AT. Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI. Health Serv Res 2002; 37(2): 433-455.
9. Zarkin GA, Galinis DN, French MT, Fountain DL, Ingram PW, Guyett JA. Financing strategies for drug abuse treatment programs. J Subst Abuse Treat 1995; 12(6): 385-399.
10. French MT, McGeary KA. Estimating the economic cost of substance abuse treatment. Health Econ 1997; 6(5): 539-544.
11. French MT. Economic evaluation of drug abuse treatment programs: methodology and findings. Am J Drug Alcohol Abuse 1995; 21(1): 111-135.
12. French MT. Economic evaluation of alcohol treatment services. Recent Dev Alcohol 2001; 15: 209-228.
13. Roebuck MC, French MT, McLellan AT. DATStats: results from 85 studies using the Drug Abuse Treatment Cost Analysis Program. J Subst Abuse Treat 2003; 25(1): 51-57.
14. Alexandre PK, Roebuck MC, French MT, Chitwood DD, McCoy CB. Problem drinking, health services utilization, and the cost of medical care. Recent Dev Alcohol 2001; 15: 285-298.
15. Alexandre PK, Roebuck MC, French MT, Barry M. The cost of residential addiction treatment in public housing. J Subst Abuse Treat 2003; 24(4): 285-290.
16. Bradley CJ, French MT, Rachal JV. Financing and cost of standard and enhanced methadone treatment. J Subst Abuse Treat 1994; 11(5): 433-442.
17. French MT, McGeary KA. Estimating the economic cost of substance abuse treatment. Health Econ 1997; 6(5): 539-544.
18. Bertsch D, Mertz A. Correction costs: issues and difficulties. South Dakota Legislative Research Council Issue memorandum 97-27, May 1998, 1-7.
19. Schuman AM. The cost of correctional services: Exploring a portly charted terrain. Research in Corrections 1989; 2(1): 27-34.
20. Wayson BL, Funke GS. What price justice? The Jefferson Institute of Washington DC, 1989.
21. Cohen MA, Miller TR. The cost of mental health care for victims of crime. Journal of Interpersonal Violence 1998; 13(1): 93-110.
22. Jerrell JM, Hu T, Ridgely MS. Cost-effectiveness of substance disorder intervention for people with severe mental illness. J Mental Health Administration 1994; 21: 3.
23. Pearson FS, Lipton DS. A meta analytical review of the effectiveness of corrections based treatments for drug abuse. The Prison Journal 1999; 79 (4): 384-410.
24. Alemi F, Sullivan T. A Standardized Survey of Program Activities through Time-in-Between Discharges. George Mason University, 2004.
25. Alemi F, Taxman F, Doyon V, Thanner M. Cost and benefit of combining probation and treatment. Interim report to National Institute of Drug Abuse, 2001.
26. French MT, Dunlap LJ, Zarkin GA, McGeary KA, McLellan AT. A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP). J Subst Abuse Treat 1997; 14(5): 445-455.
27. Callahan R, Kaune M, Slavings R. Statewide time study of supervision and parole officercs. Virginia Department of Corrections, April 2000.
28. Mcdonald D, Fournier E, Russell-Einhourn M, Crawford S. Private Prisons in the United States. An Assessment of Current Practice. Report of Abt Associates Inc. Bethesda MD, July 16, 1998.
29. Bradley CJ, French MT, Rachal JV. Financing and cost of standard and enhanced methadone treatment. J Subst Abuse Treat 1994; 11(5): 433-442.
30. French MT, McGeary KA. Estimating the economic cost of substance abuse treatment Health Econ 1997; 6(5): 539-544.